Bis(styryl)benzene Probes for Targeting Early-Stage Amyloid-β Aggregates in Alzheimer's Disease
{{output}}
With the recent FDA approval of antibody-based therapeutics for Alzheimer's disease (AD), the need for diagnostic tools capable of detecting the disease at the earliest stages has become increasingly urgent. Although small molecules offer advantages in terms ... ...